Cargando…
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension
INTRODUCTION: Pulmonary vascular remodelling in chronic obstructive pulmonary disease (COPD) has detrimental consequences for lung physiology. The aim of our study was to provide a comprehensive size-based morphometric quantification of pulmonary arterial remodelling in smokers and in patients with...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720549/ https://www.ncbi.nlm.nih.gov/pubmed/36478915 http://dx.doi.org/10.1183/23120541.00254-2022 |
_version_ | 1784843581850124288 |
---|---|
author | Bhattarai, Prem Lu, Wenying Gaikwad, Archana Vijay Dey, Surajit Chia, Collin Larby, Josie Haug, Greg Hardikar, Ashutosh Williams, Andrew Kaur Singhera, Gurpreet Hackett, Tillie-Louise Eapen, Mathew Suji Sohal, Sukhwinder Singh |
author_facet | Bhattarai, Prem Lu, Wenying Gaikwad, Archana Vijay Dey, Surajit Chia, Collin Larby, Josie Haug, Greg Hardikar, Ashutosh Williams, Andrew Kaur Singhera, Gurpreet Hackett, Tillie-Louise Eapen, Mathew Suji Sohal, Sukhwinder Singh |
author_sort | Bhattarai, Prem |
collection | PubMed |
description | INTRODUCTION: Pulmonary vascular remodelling in chronic obstructive pulmonary disease (COPD) has detrimental consequences for lung physiology. The aim of our study was to provide a comprehensive size-based morphometric quantification of pulmonary arterial remodelling in smokers and in patients with small airway disease (SAD) or COPD. METHOD: Movat's pentachrome staining was performed on lung resections for 46 subjects: 12 never-smoker normal controls (NC), six normal lung function smokers (NLFS), nine patients with SAD, nine patients with mild-to-moderate COPD who were current smokers (COPD-CS) and 10 patients with mild-to-moderate COPD who were ex-smokers (COPD-ES). Following a size-based classification of pulmonary arteries, image analysis software was used to measure their number, total wall thickness, individual layer thickness and elastin percentage. RESULTS: All pathological groups showed decreased numbers of pulmonary arteries compared with the NC group in all artery sizes. Arterial wall thickness was greater in NLFS and COPD-CS than in NC. Thickness in COPD-ES was decreased compared with COPD-CS. Intimal thickness was greater in all pathological groups in all arterial sizes than in the NC group. Medial thickness was also greater in small and medium arteries. Intimal thickness of larger arteries in COPD-CS correlated negatively to forced expiratory volume in 1 s/forced vital capacity (FVC) % and forced expiratory flow at 25–75% of FVC. Elastin deposition in small arteries was greatest in COPD-CS. Intimal elastin deposition had a more negative correlation with intimal thickness in NLFS and SAD than in COPD-CS. CONCLUSION: Smoking, SAD and mild-to-moderate COPD are associated with pruning and a decrease in the number of pulmonary arteries, increased wall thickness and variable elastin deposition. These changes were associated with worse airway obstruction. |
format | Online Article Text |
id | pubmed-9720549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-97205492022-12-06 Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension Bhattarai, Prem Lu, Wenying Gaikwad, Archana Vijay Dey, Surajit Chia, Collin Larby, Josie Haug, Greg Hardikar, Ashutosh Williams, Andrew Kaur Singhera, Gurpreet Hackett, Tillie-Louise Eapen, Mathew Suji Sohal, Sukhwinder Singh ERJ Open Res Original Research Articles INTRODUCTION: Pulmonary vascular remodelling in chronic obstructive pulmonary disease (COPD) has detrimental consequences for lung physiology. The aim of our study was to provide a comprehensive size-based morphometric quantification of pulmonary arterial remodelling in smokers and in patients with small airway disease (SAD) or COPD. METHOD: Movat's pentachrome staining was performed on lung resections for 46 subjects: 12 never-smoker normal controls (NC), six normal lung function smokers (NLFS), nine patients with SAD, nine patients with mild-to-moderate COPD who were current smokers (COPD-CS) and 10 patients with mild-to-moderate COPD who were ex-smokers (COPD-ES). Following a size-based classification of pulmonary arteries, image analysis software was used to measure their number, total wall thickness, individual layer thickness and elastin percentage. RESULTS: All pathological groups showed decreased numbers of pulmonary arteries compared with the NC group in all artery sizes. Arterial wall thickness was greater in NLFS and COPD-CS than in NC. Thickness in COPD-ES was decreased compared with COPD-CS. Intimal thickness was greater in all pathological groups in all arterial sizes than in the NC group. Medial thickness was also greater in small and medium arteries. Intimal thickness of larger arteries in COPD-CS correlated negatively to forced expiratory volume in 1 s/forced vital capacity (FVC) % and forced expiratory flow at 25–75% of FVC. Elastin deposition in small arteries was greatest in COPD-CS. Intimal elastin deposition had a more negative correlation with intimal thickness in NLFS and SAD than in COPD-CS. CONCLUSION: Smoking, SAD and mild-to-moderate COPD are associated with pruning and a decrease in the number of pulmonary arteries, increased wall thickness and variable elastin deposition. These changes were associated with worse airway obstruction. European Respiratory Society 2022-12-05 /pmc/articles/PMC9720549/ /pubmed/36478915 http://dx.doi.org/10.1183/23120541.00254-2022 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Original Research Articles Bhattarai, Prem Lu, Wenying Gaikwad, Archana Vijay Dey, Surajit Chia, Collin Larby, Josie Haug, Greg Hardikar, Ashutosh Williams, Andrew Kaur Singhera, Gurpreet Hackett, Tillie-Louise Eapen, Mathew Suji Sohal, Sukhwinder Singh Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension |
title | Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension |
title_full | Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension |
title_fullStr | Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension |
title_full_unstemmed | Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension |
title_short | Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension |
title_sort | arterial remodelling in smokers and in patients with small airway disease and copd: implications for lung physiology and early origins of pulmonary hypertension |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720549/ https://www.ncbi.nlm.nih.gov/pubmed/36478915 http://dx.doi.org/10.1183/23120541.00254-2022 |
work_keys_str_mv | AT bhattaraiprem arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT luwenying arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT gaikwadarchanavijay arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT deysurajit arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT chiacollin arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT larbyjosie arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT hauggreg arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT hardikarashutosh arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT williamsandrew arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT kaursingheragurpreet arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT hacketttillielouise arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT eapenmathewsuji arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension AT sohalsukhwindersingh arterialremodellinginsmokersandinpatientswithsmallairwaydiseaseandcopdimplicationsforlungphysiologyandearlyoriginsofpulmonaryhypertension |